Presentations / PDFs

Prostate

Baum et al_2015_NM_Theranostik des metastasierten Prostatakarzinoms mittels Lu-177 PSMA-Liganden in Kombination mit Ga-68 PSMA PETCT

Baum_2016_JNMMI_Lu-177 Labeled PSMA Radioligand Therapy of mCRPC - Safety and Efficacy

Eiber-Baum_Editorial_Prostatakarzinom- Bildgebung und Therapie im Wandel

Kratochwil_2016_JNMMI_225Ac-PSMA-617 for PSMA targeting alpha-radiation therapy of patients with metastatic castration-resistant prostate cancer

Kulkarni&Baum_2016_JNMMI_PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer - The Bad Berka Experience Since 2013

Maina_2015_EJNMMI_Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PETCT

Rahbar_2016_JNMMI_German multicenter study investigating 177Lu-PSMA-617 radioligand therapy in advanced prostate cancer patients

Rai_2016_Urology_The Role of PET With Ga-68 PSMA in the Management of Patients

Weineisen_2015_JNMMI_Ga-68 and Lu-177 labeled PSMA I&T

Powered by Phoca Download